Caricamento...
Noncytotoxic Pyrrolobenzodiazepine–Ciprofloxacin Conjugate with Activity against Mycobacterium tuberculosis
[Image: see text] The development of new antitubercular agents for the treatment of infections caused by multidrug-resistant (MDR) Mycobacterium tuberculosis is an urgent priority. Pyrrolobenzodiazepines (PBDs) are a promising class of antibacterial agents that were initially discovered and isolated...
Salvato in:
| Pubblicato in: | ACS Omega |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Chemical Society
2019
|
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6921268/ https://ncbi.nlm.nih.gov/pubmed/31867477 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsomega.9b00834 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|